The central mechanism is clomiphene's blockade of estrogen receptors at the hypothalamus and pituitary. Under normal conditions, circulating estradiol feeds back to suppress GnRH from the hypothalamus and gonadotropins (LH and FSH) from the pituitary — this is the body's natural brake on testosterone production. Clomiphene occupies those receptors without activating them, effectively removing the brake. The hypothalamus and pituitary interpret this as low estrogen and respond by increasing GnRH, LH, and FSH output. The testes receive the LH signal and ramp up testosterone synthesis in the Leydig cells, while FSH simultaneously supports sperm production in the Sertoli cells.

Anastrozole then operates downstream, reducing the conversion of the newly elevated testosterone into estradiol in peripheral tissues, protecting against estrogen excess. DHEA and 7-Keto DHEA provide adrenal precursor support and metabolic contributions, while progesterone supports both the upstream steroidogenic pathway and sperm function.

The net effect is increased endogenous testosterone — both systemic and intratesticular — without the testicular suppression, infertility risk, or need for injection that accompanies exogenous testosterone therapy.

Test Booster is prescribed for adult men with confirmed hypogonadism — low testosterone supported by both symptoms and laboratory findings — who are seeking to restore testosterone levels while preserving testicular size, function, and fertility potential. It is particularly relevant for men who are actively trying to conceive or wish to maintain the option of future fertility, men who prefer an oral medication over injectable testosterone, men with mild-to-moderate testosterone deficiency, and those who have experienced testicular atrophy or fertility concerns as a side effect of prior testosterone therapy.

Candidacy is determined by a licensed healthcare provider based on a review of serum testosterone levels, symptom profile, reproductive goals, body composition, and individual health history.

Standard dosing: 1 capsule taken orally daily, on a 5-days-on / 2-days-off schedule, as directed by the prescribing provider.

The cyclic dosing pattern (5 on, 2 off) is a common approach with clomiphene-based protocols designed to prevent receptor desensitization and maintain the responsiveness of the HPG axis over time. Do not adjust your dose or alter the dosing schedule without consulting your provider.

This is a prescription-only medication. It must be used under medical supervision with appropriate baseline and follow-up laboratory monitoring.

As with all hormone therapy, regular monitoring is essential. Patients should expect baseline bloodwork before starting, including serum total and free testosterone, estradiol, LH, FSH, and a complete metabolic panel. Follow-up labs are typically checked after 6–8 weeks to assess response and guide any dose adjustments. Ongoing monitoring of testosterone and estradiol levels allows the prescriber to evaluate whether the anastrozole component is needed, whether dosing is achieving the desired hormonal effect, and whether any side effects warrant adjustment.

Common side effects may include headache, nausea, and visual disturbances such as blurring or light sensitivity — these are associated primarily with clomiphene and are typically dose-dependent and reversible. Estrogenic side effects including gynecomastia, bloating, and mood fluctuations may occur, particularly in men with higher aromatase activity, and are addressed by the anastrozole component.

Anastrozole-related effects at the low dose used in this formulation are generally mild but may include joint discomfort, fatigue, skin changes, or mood changes. Anastrozole's estrogen-lowering action, while protective against excess conversion, can cause symptoms of estrogen deficiency if levels fall too low — another reason why monitoring the testosterone-to-estradiol ratio is important during therapy.

Fertility note: While this formulation is often used specifically to preserve or restore fertility, patients actively trying to conceive should discuss the timing and structure of therapy with their prescriber, as clomiphene's effects on sperm parameters and ovulation induction in female partners may be relevant context depending on the clinical situation.

Not for use in women (in most contexts): Clomiphene is used clinically in women for ovulation induction but at different doses and under different protocols. This compounded formulation is designed for male hypogonadism. Women who are pregnant or may become pregnant should not use this product.

Store at controlled room temperature, away from heat, moisture, and direct light. A cool, dry location away from bathroom humidity is recommended. Keep in the original container with the lid tightly closed. Keep out of reach of children. Dispose of unused medication through a pharmaceutical take-back program or in accordance with your pharmacy's guidance.